Literature DB >> 7807005

The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent.

C C Stebbins1, G E Loss, C G Elias, A Chervonsky, A J Sant.   

Abstract

Recently several cell lines have been identified with mutations in a major histocompatibility complex (MHC)-linked protein that lead to defects in class II-restricted antigen presentation and a defect in the formation of class II SDS-stable dimers. The defect in these cells has recently been shown to result from the inability to express the MHC-encoded nonclassical class II molecule called DM. To further examine the role of DM in class II-restricted antigen presentation, we asked if this defect would equally affect different allelic and species variants of class II molecules. To investigate this, we transfected the parent cell lines T1 and 8.1.6 and their respective antigen presentation mutants T2 and 9.5.3 with the genes encoding I-Ad and examined the derived transfectants for their ability to present antigen, the conformation of I-Ad at the cell surface, association of I-Ad with invariant chain (Ii), and the ability to form I-Ad SDS-stable dimers. The lack of functional DM expression did not affect any of the anti-I-Ad monoclonal antibody (mAb) epitopes tested or the ability of I-Ad to associate and dissociate with Ii. Surprisingly, these studies also revealed that the antigen presentation defect observed for DR in the 9.5.3 cells did not compromise I-Ad-restricted antigen presentation. In addition, we found that the level of SDS-stable dimer formation did not correlate with antigen presentation capacity for I-Ad and that the amount of SDS-stable I-Ad dimer depends on the cellular context in which the class II molecule is expressed. Our results suggest that the ability to form SDS-stable dimer is not strictly correlated with class II-restricted antigen presentation. Finally, when two allelic forms of murine class II molecules were compared in the defective T2 cell line, it was found that I-Ak but not I-Ad forms SDS-stable dimers equivalent to that seen in the parental cell lines. Overall, our results suggest that DM may modulate rather than play a requisite role in I-Ad-restricted antigen presentation and SDS-stable dimer formation and that dependency on DM may be allele or species specific.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7807005      PMCID: PMC2191808          DOI: 10.1084/jem.181.1.223

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  48 in total

1.  Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.

Authors:  L Teyton; D O'Sullivan; P W Dickson; V Lotteau; A Sette; P Fink; P A Peterson
Journal:  Nature       Date:  1990-11-01       Impact factor: 49.962

2.  Structurally interdependent and independent regions of allelic polymorphism in class II MHC molecules. Implications for Ia function and evolution.

Authors:  N S Braunstein; R N Germain; K Loney; N Berkowitz
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

3.  Invariant chain influences the immunological recognition of MHC class II molecules.

Authors:  M Peterson; J Miller
Journal:  Nature       Date:  1990-05-10       Impact factor: 49.962

4.  Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments.

Authors:  P J Peters; J J Neefjes; V Oorschot; H L Ploegh; H J Geuze
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

5.  Mutations affecting antigen processing impair class II-restricted allorecognition.

Authors:  T Cotner; E Mellins; A H Johnson; D Pious
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

6.  Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding.

Authors:  P A Roche; P Cresswell
Journal:  Nature       Date:  1990-06-14       Impact factor: 49.962

7.  A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.

Authors:  P Gunning; J Leavitt; G Muscat; S Y Ng; L Kedes
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  Intracellular competition for component chains determines class II MHC cell surface phenotype.

Authors:  A J Sant; R N Germain
Journal:  Cell       Date:  1989-06-02       Impact factor: 41.582

Review 9.  Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens.

Authors:  R DeMars; C C Chang; S Shaw; P J Reitnauer; P M Sondel
Journal:  Hum Immunol       Date:  1984-10       Impact factor: 2.850

10.  Structural differences in cell surface T25 polypeptides from thymocytes and cloned T cells.

Authors:  M Sarmiento; M R Loken; F W Fitch
Journal:  Hybridoma       Date:  1981
View more
  22 in total

1.  Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM.

Authors:  J A Villadangos; C Driessen; G P Shi; H A Chapman; H L Ploegh
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

Review 2.  Antigen-presenting cells in rheumatoid arthritis.

Authors:  R Thomas
Journal:  Springer Semin Immunopathol       Date:  1998

3.  Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides.

Authors:  A V Chervonsky; R M Medzhitov; L K Denzin; A K Barlow; A Y Rudensky; C A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

Review 4.  Protein sorting within the MHC class II antigen-processing pathway.

Authors:  M S Marks
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

Review 5.  Selection of the MHC class II-associated peptide repertoire by HLA-DM.

Authors:  S O Arndt; A B Vogt; G J Hämmerling; H Kropshofer
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

Review 6.  HLA-DM: arbiter conformationis.

Authors:  Andrea Ferrante
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

7.  Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome.

Authors:  S Kovats; G T Nepom; M Coleman; B Nepom; W W Kwok; J S Blum
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41.

Authors:  B Fineschi; L S Arneson; M F Naujokas; J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

Review 9.  The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway.

Authors:  Monika-Sarah E D Schulze; Kai W Wucherpfennig
Journal:  Curr Opin Immunol       Date:  2011-12-02       Impact factor: 7.486

10.  Protein Vaccination Directs the CD4+ T Cell Response toward Shared Protective Epitopes That Can Be Recalled after Influenza Virus Infection.

Authors:  Ajitanuj Rattan; Katherine A Richards; Zackery A G Knowlden; Andrea J Sant
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.